Vocal Biomarkers Market By Therapeutic Applications (Psychiatric Disorders, Parkinson’s Disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and Others), By End user (Hospitals, Health Insurers, Academic Institutes, and Government Organizations) and By Region - Trends, Analysis and Forecast till 2034

Vocal Biomarkers Market size was valued at about USD 2.6 Billion in 2024 and expected to grow at CAGR of 15.10% to extend a value of USD 9.4 Billion by 2034.

Sound vibrations have been used as biomarkers in the diagnosis of various mental health disorders such as anxiety disorders, attention deficit and depression. Recent advancement in research on these aspects of sound of individual has led to emergence of the vocal biomarkers, which helps to detect, record and analyze the various types of disease based on sound characteristics. Advantage with vocal biomarkers is that it can be used to diagnose even patient who is remotely located.

This makes it ideal diagnostic tool for telemedicine and related healthcare delivery. Moreover, vocal biomarker would be cost effective due to its noninvasive nature as against traditional biomarker, which are costly and causes significant healthcare burden for governments as well as insurance payer organization. In addition, these biomarkers would allow self-diagnosis as well as self-medication which would significantly increase the demand for vocal biomarkers in near future. 

                      For More Report Details, Download Free Sample PDF

Increasing incidence of the mental disorder

Important driver responsible for growth of vocal biomarkers market are increasing incidence of the mental disorder, neurological disorder and chronic disease such as cardiovascular disease. According to Parkinson’s Foundation data, close to one million people will be living with Parkinson\'s disease in the U.S. by 2020.Approximately 60,000 U.S. population are diagnosed with Parkinson\'s disease each year. Moreover chronic disease causes greatest number of deaths worldwide which would lead to increased focus on early diagnosis of these disease. In addition increased commercial activities and academic focus to develop vocal biomarker would help to early launch of vocal biomarker based products into the market.

Early discovery of disease, especially in the event of serious illness, might be the difference between life and death for a person. Technology has aided in the development of various innovative technologies that assist doctors and patients in detecting diseases at an early stage, lowering mortality rates. The voice biomarker is one such advancement in medical science. A biomarker is a symptom or medical condition that affects the human body. It is the voice pattern in the case of vocal biomarkers. The market for vocal biomarkers has been steadily rising in recent years and is projected to continue to do so in the coming years.

Vocal biomarkers market is segmented based application, end user and region.

On the basis of application, vocal biomarker market is segmented into (Psychiatric Disorders, Parkinson’s disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and others). On the basis of end user, vocal biomarkers market is segmented into Hospitals, Health Insurers, Academic Institutes, and Government Organizations.

Regional Insights:

Vocal Biomarkers Market accounted for US$ 1.65 billion in 2020 and is estimated to be US$ 6.18 billion by 2030 and is anticipated to register a CAGR of 14.1%. On region the Global Vocal Biomarker Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The major shareholder in the vocal biomarkers market is North America, which has the most technical and healthcare breakthroughs. Apart from health, the increased focus on national security and the desire to maintain the status of world superpower is driving demand for vocal biomarkers in the defence sector. Europe is also vital to the worldwide market for voice biomarkers. Existing players are attracted by the predicted increase in demand from Asia Pacific. The market for vocal biomarkers will rise as countries like India and China improve their defence and healthcare systems.

Report scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Vocal Biomarkers Market report based on Therapeutic Application, End-User and Region.                                                              

Vocal Biomarkers Market, By Region:

• North America
  • U.S.
    • Canada
    • Europe
      • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Key players operating in the vocal biomarkers market include Beyond Verbal, Inc., Sonde Health, IBM, Cogito Corporation and Sharecare, Inc.

• Beyond Verbal Inc.
• Sonde Health
• IBM
• Cogito Corporation
• Sharecare, Inc.